Q32 Bio (QTTB) SIGNAL-AD trial did not achieve its primary endpoint, SIGNAL-AA demonstrated encouraging clinical activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. BAJAJHFL:I
9. CCHGY
10. PRY:IM

Go back to Q32 Bio (QTTB) SIGNAL-AD trial did not achieve its primary endpoint, SIGNAL-AA demonstrated encouraging clinical activity
(NASDAQ: QTTB) Delayed: 13.09 +0.49 (3.89%)
Previous Close $12.60    52 Week High $ 
Open $12.68    52 Week Low $ 
Day High $13.30    P/E N/A 
Day Low $12.54    EPS $ 
Volume 162,682